Therapeutic area crossroads: Anti-angiogenesis

Nature Reviews Drug Discovery

Volumn 7, Issue 2, 2008, Pages 115-116

  Million, Ryan P ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGN 211745; ANGIOGENESIS INHIBITOR; ATG 003; BEVACIZUMAB; BEVASIRANIB; LENALIDOMIDE; OT 551; PEGAPTANIB; RANIBIZUMAB; SUNITINIB; TELBERMIN; TG 100801; THALIDOMIDE; UNCLASSIFIED DRUG; VATALANIB; VOLOCIXIMAB; XL 784;

ANTIANGIOGENIC ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; BREAST CANCER; CLINICAL TRIAL; COLON CANCER; COLORECTAL CANCER; CROHN DISEASE; DIABETIC FOOT; DIABETIC MACULAR EDEMA; DRUG COST; DRUG EFFICACY; DRUG INDICATION; GLAUCOMA; HEALTH INSURANCE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; NEUROPATHIC PAIN; OFF LABEL DRUG USE; PRIORITY JOURNAL; PSORIASIS; RETINA MACULA AGE RELATED DEGENERATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 38849209802     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd2507     Document Type: Article

References (9)

1. Folkman, J. Angiogenesis: An organizing principle for drug discovery? Nature Rev. Drug Discov. 6, 273-286 (2007).
2. The Eye Diseases Research Group. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 122, 564-572 (2004).
3. Genentech. Lucentis US package insert. Genentech web site [online], (2007)
4. US Department of Health and Human Services (HHS). Your Medicare Benefits. HHS web site [online], (2006)
5. US National Eye Institute/National Institutes of Health (NEI/NIH). Press release: National Institutes of Health Stimulates the Development and Testing of New Therapies for Advanced Age-Related Macular Degeneration [AMD]. NEI/NIH web site [online], (2006).
6. National Institute for Health Research (NIHR). A Randomised Controlled Trial of Alternative Treatments to Inhibit VEGF in Age-Related Choroidal Neovascularization ((IVAN). NIHR web site [online], (2007).
7. Genentech. Commitment to Patient Access. Genentech web site [online], (2007).
8. Goldstein, J. & Chase M. Genentech to limit Avastin availability. The Wail Street Journal (12 Oct 2007).
9. American Academy of Ophthalmology (AAO). Solution to Avastin Access Found through a Joint Effort by the Academy, ASRS and Genentech. AAO web site [online], (2007).